Low bacterial contamination of nebulizers in home treatment of cystic fibrosis patients

Journal of Hospital Infection

Volumn 36, Issue 3, 1997, Pages 201-207

  Jakobsson, B M ^a   Onnered A B ^a   Hjelte, L ^a   Nystrom B ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bacterial contamination; Cystic fibrosis; Inhalation; Nebulizers; Respiratory tract infections

Indexed keywords

ACETIC ACID; TAP WATER;

ADOLESCENT; ADULT; ARTICLE; BACTERIUM CONTAMINATION; BURKHOLDERIA CEPACIA; CHILD; CLINICAL ARTICLE; CYSTIC FIBROSIS; DISINFECTION; FEMALE; FLORA; HOME CARE; HUMAN; MALE; NEBULIZER; PATIENT COMPLIANCE; PSEUDOMONAS AERUGINOSA; SPUTUM CULTURE; STREPTOCOCCUS GROUP A; SWEDEN;

EID: 0030760898     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-6701(97)90195-X     Document Type: Article

References (17)

1. Pitchford KC, Corey M, Highsmith A, et al. Pseudomonas species contamination of cystic fibrosis patients' home inhalation equipment. J Pediatr 1987; 111: 212-216.
2. Barnes K, Clifford R, Holgate ST, Murphy D, Comber P, Bell E. Bacterial contamination of home nebulisers. Br Med J 1987; 295: 812.
3. Higgs CMB, Jones P, Tanser AR. Bacterial contamination of home nebulizers. Br Med J 1987; 292: 1281-1282.
4. Wexler MR, Rhame FS, Blumenthal MN, et al. Transmission of Gram-negative bacilli to asthmatic children via home nebulizers. Ann Allergy 1991; 66: 267-271.
5. Hutchinson GR, Parker S, Pryor JA, et al. The contamination of CF home-use nebulisers. Abstract. EWGCF 1994, Paris, 05 29-06 03.
6. Botman MJ, de Krieger RA. Contamination of small-volume medication nebulizers and its association with oropharyngeal colonization. J Hosp Infect 1987; 10: 204-208.
7. Warachit B. Nosocomial pneumonia caused by contaminated nebulizer. J Med Assoc Thai 1988; 71 (Suppl 3): 33-34.
8. Mastro TD, Fields BS, Breiman RF, Campbell J, Plikaytis BD, Spika JS. Nosocomial Legionnaires' disease and use of medication nebulizers. J Infect Dis 1991; 163: 667-671.
9. Govan JR, Nelson JW. Microbiology of lung infection in cystic fibrosis. Br Med Bull 1992; 48: 912-930.
10. Isles A, Maclusky I, Corey M, et al. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr 1984; 104: 206-210.
11. Simmonds EJ, Conway SP, Ghoneim ATM, Ross H, Littlewood JM. Pseudomonas cepacia: a new pathogen in patients with cystic fibrosis referred to a large centre in the United Kingdom. Arch Dis Child 1990; 65: 874-877.
12. Hoiby N, Pederson SS. Estimated risk of cross-infection with Pseudomonas aeruginosa in Danish cystic fibrosis patients. Acta Paediatr Scand 1989; 78: 395-404.
13. LiPuma JJ, Dasen SE, Nielson DW, Stern RC, Stull TL. Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis. Lancet 1990; 336: 1094-1096.
14. Burdge DR, Nakielna EM, Noble MA, Case-control and vector studies of nosocomial acquisition of Pseudomonas cepacia in adult patients with cystic fibrosis. Infect Control Hosp Epidemiol 1993; 14: 127-130.
15. Smith DL, Gumery LB, Smith EG, Stableforth DE, Kaufmann ME, Pitt TL. Epidemic of Pseudomonas cepacia in an adult fibrosis unit: evidence of person-to-person transmission. J Clin Microbiol 1993; 31: 3017-3022.
16. Nyström B. Disinfection of surgical instruments. J Hosp Infect 1981; 2: 363-368.
17. Childs HJ, Dezateux CA. A national survey of nebuliser use. Arch Dis Child 1991; 66: 1351-1353.